JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Financials | 10.12% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 7.97% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4901
Star Holdings Shares of Beneficial Interest
STHO
$118M
| $445K | ﹤0.01% |
45,688
+23,075
| +102% | +$269K |
|
4902
Enliven Therapeutics
ELVN
$4.31B
| $444K | ﹤0.01% |
19,745
-1,062
| -5% | -$27.5K |
|
4903
PUT
CoStar Group
CSGP
$13.1B
| $444K | ﹤0.01% |
+6,200
| New | +$468K |
|
4904
Alta Equipment Group
ALTG
$237M
| $443K | ﹤0.01% |
67,722
+16,304
| +32% | +$114K |
|
|
HTT
4905
High Templar Tech Ltd
HTT
$393M
| $442K | ﹤0.01% |
+156,844
| New | +$395K |
|
4906
CALL
Nice
NICE
$5.99B
| $442K | ﹤0.01% |
2,600
-200
| -7% | -$35.7K |
|
4907
AudioCodes
AUDC
$250M
| $441K | ﹤0.01% |
45,299
-58,738
| -56% | -$541K |
|
|
SVCO
4908
Silvaco Group
SVCO
$246M
| $441K | ﹤0.01% |
54,583
-54,866
| -50% | -$457K |
|
4909
AB Tax-Aware Long Municipal ETF
TAFL
$62.2M
| $441K | ﹤0.01% |
17,505
-9,918
| -36% | -$253K |
|
4910
Fidelity International High Dividend ETF
FIDI
$365M
| $440K | ﹤0.01% |
22,573
+6,024
| +36% | +$123K |
|
4911
Tejon Ranch
TRC
$442M
| $440K | ﹤0.01% |
27,666
+18,149
| +191% | +$293K |
|
4912
Fresenius Medical Care
FMS
$12.7B
| $440K | ﹤0.01% |
19,426
+9,524
| +96% | +$207K |
|
4913
iShares MSCI Qatar ETF
QAT
$63.5M
| $439K | ﹤0.01% |
24,472
-1,822
| -7% | -$33.2K |
|
4914
Anavex Life Sciences
AVXL
$298M
| $438K | ﹤0.01% |
40,823
-1,742
| -4% | -$13.4K |
|
4915
Information Services Group
III
$250M
| $438K | ﹤0.01% |
131,103
-166,627
| -56% | -$557K |
|
4916
ProShares Short 7-10 Year Treasury
TBX
$20.9M
| $437K | ﹤0.01% |
15,037
+5,343
| +55% | +$156K |
|
|
BZUN
4917
Baozun
BZUN
$165M
| $436K | ﹤0.01% |
160,178
-1,422
| -0.9% | -$4.3K |
|
4918
Portillo's
PTLO
$374M
| $434K | ﹤0.01% |
46,179
-735
| -2% | -$8.41K |
|
4919
PUT
Teva Pharmaceuticals
TEVA
$42.8B
| $432K | ﹤0.01% |
19,600
-655,400
| -97% | -$11.9M |
|
4920
CALL
Wave Life Sciences
WVE
$1.07B
| $432K | ﹤0.01% |
+34,900
| New | +$466K |
|
4921
Acacia Research
ACTG
$448M
| $429K | ﹤0.01% |
98,841
+71,153
| +257% | +$322K |
|
|
HLVX
4922
DELISTED
HilleVax
HLVX
| $429K | ﹤0.01% |
207,151
+193,124
| +1,377% | +$363K |
|
4923
Pioneer Bancorp
PBFS
$421M
| $427K | ﹤0.01% |
37,024
+21,904
| +145% | +$250K |
|
|
STRS
4924
DELISTED
STRATUS PPTYS INC
STRS
| $425K | ﹤0.01% |
20,460
+10,857
| +113% | +$261K |
|
4925
Hertz
HTZ
$798M
| $424K | ﹤0.01% |
115,754
-50,791
| -30% | -$184K |
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.